No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: FOLFOX in combination with nivolumab and trastuzumab improves survival in metastatic ERBB2⁺ esophagogastric adenocarcinoma

byTeddy Guo

July 20, 2022

in StudyGraphics

Reading Time: 1 min read

Case management program for patient social needs reduces future healthcare use

RelatedReports

Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Chronic Disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

January 13, 2026

Gastric bypass surgery reduces cardio-metabolic risk factors

Chronic Disease

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

October 28, 2025

Adalimumab use results in high clinical response rate in hidradenitis suppurativa

All Specialties

Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty

September 23, 2025

Half of parents aware of CT radiation cancer risk

AI Roundup

AI scans detect pancreatic cancer years before clinical diagnosis

July 30, 2025

Few older adolescents meet recommended levels of physical activity

Exercise therapy combined with corticosteroid injections associated with clinical improvement of Achilles tendinopathy

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Bridging therapy is superior to direct thrombectomy within 4.5 hours of acute ischemic stroke

Wellness Check: Spirituality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports